FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)

PMA: P990041 · Supplement: S005 · Decision Mar 26, 2004
Classifications
1
FEI Numbers
27
Registration Numbers
27

Basic Information

Device Name
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
Trade Name
DIASORIN ETI-AB-EBK PLUS
PMA Number
P990041
Supplement Number
S005
Device Class
FDA Class 3
Product Code
LOM
Generic Name
Test, hepatitis b (b core, be antigen, be antibody, b core igm)
Medical Specialty
Unknown
Advisory Committee
Microbiology
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
March 26, 2004
Date Received
March 11, 2004
Supplement Type
30-Day Notice
Expedited Review
N

Advisory Committee Statement

CHANGE IN THE QUALITY CONTROL TEST OF AN INCOMING RAW MATERIAL USED IN THE PREPARATION OF COATED STRIPS OF THE ETI-AB-EBK PLUS WHICH IS AN IN VITRO ENZYME IMMUNOASSAY INTENDED FOR USE IN THE QUALITATIVE DETERMINATION OF TOTAL ANTIBODIES TO HEPATITIS B E ANTIGEN IN HUMAN SERUM OR PLASMA.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOM Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)